Following David Mckinley’s last HSIC Sell transaction on March 15, 2016, the stock climbed by 5.4%.
Based on Henry Schein’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $3.28 billion and quarterly net profit of $121 million. In comparison, last year the company earned revenue of $3.16 billion and had a net profit of $138 million. HSIC’s market cap is $13.6B and the company has a P/E ratio of 34.83. Currently, Henry Schein has an average volume of 1.29M.
Based on 9 analyst ratings, the analyst consensus is Hold with an average price target of $85.71, reflecting a -5.2% downside.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments.